CX3CL1 and neoplasm: Expression of chemokine receptors that match ligands secreted by the tumor such as CCL2, CCL22, CXCL16, CX3CL1, CXCL1 and CXCL8 can enable CD8+ T cells to enter the tumor [9–13].